186 related articles for article (PubMed ID: 36552262)
1. A Systems Biology and LASSO-Based Approach to Decipher the Transcriptome-Interactome Signature for Predicting Non-Small Cell Lung Cancer.
Ahmed F; Khan AA; Ansari HR; Haque A
Biology (Basel); 2022 Nov; 11(12):. PubMed ID: 36552262
[TBL] [Abstract][Full Text] [Related]
2. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
[TBL] [Abstract][Full Text] [Related]
3. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
Yue C; Ma H; Zhou Y
PeerJ; 2019; 7():e8128. PubMed ID: 31803536
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
5. Construction of a redox-related gene signature for overall survival prediction and immune infiltration in non-small-cell lung cancer.
Miao TW; Yang DQ; Gao LJ; Yin J; Zhu Q; Liu J; He YQ; Chen X
Front Mol Biosci; 2022; 9():942402. PubMed ID: 36052170
[No Abstract] [Full Text] [Related]
6. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
7. Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.
Shi Y; Zhu S; Yang J; Shao M; Ding W; Jiang W; Sun X; Yao N
J Comput Biol; 2020 Sep; 27(9):1433-1442. PubMed ID: 32048869
[TBL] [Abstract][Full Text] [Related]
8. Immune-related gene signature to predict TACE refractoriness in patients with hepatocellular carcinoma based on artificial neural network.
Xu Q; Wang C; Yin G
Front Genet; 2022; 13():993509. PubMed ID: 36685822
[No Abstract] [Full Text] [Related]
9. Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancer.
Ding H; Shi L; Chen Z; Lu Y; Tian Z; Xiao H; Deng X; Chen P; Zhang Y
BMC Med Genomics; 2022 Sep; 15(1):187. PubMed ID: 36056349
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic analysis of underlying mechanisms of Kawasaki disease via Weighted Gene Correlation Network Analysis (WGCNA) and the Least Absolute Shrinkage and Selection Operator method (LASSO) regression model.
Xie Y; Shi H; Han B
BMC Pediatr; 2023 Feb; 23(1):90. PubMed ID: 36829193
[TBL] [Abstract][Full Text] [Related]
11. Construction and Validation of a 13-Gene Signature for Prognosis Prediction in Medulloblastoma.
Li C; Zou H; Xiong Z; Xiong Y; Miyagishima DF; Wanggou S; Li X
Front Genet; 2020; 11():429. PubMed ID: 32508873
[No Abstract] [Full Text] [Related]
12. Analysis of expression differences of immune genes in non-small cell lung cancer based on TCGA and ImmPort data sets and the application of a prognostic model.
Sun L; Zhang Z; Yao Y; Li WY; Gu J
Ann Transl Med; 2020 Apr; 8(8):550. PubMed ID: 32411773
[TBL] [Abstract][Full Text] [Related]
13. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells.
Zhang Y; He RQ; Dang YW; Zhang XL; Wang X; Huang SN; Huang WT; Jiang MT; Gan XN; Xie Y; Li P; Luo DZ; Chen G; Gan TQ
Cancer Cell Int; 2016; 16():89. PubMed ID: 27980454
[TBL] [Abstract][Full Text] [Related]
15. In silico analysis revealed the potential circRNA-miRNA-mRNA regulative network of non-small cell lung cancer (NSCLC).
Balasundaram A; C GPD
Comput Biol Med; 2023 Jan; 152():106315. PubMed ID: 36495751
[TBL] [Abstract][Full Text] [Related]
16. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
17. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
[TBL] [Abstract][Full Text] [Related]
18. Signature based on RNA-binding protein-related genes for predicting prognosis and guiding therapy in non-small cell lung cancer.
Miao TW; Chen FY; Du LY; Xiao W; Fu JJ
Front Genet; 2022; 13():930826. PubMed ID: 36118863
[No Abstract] [Full Text] [Related]
19. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
Huang H; Xu S; Chen A; Li F; Wu J; Tu X; Hu K
Anal Cell Pathol (Amst); 2021; 2021():6697407. PubMed ID: 33833937
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression.
He B; Quan LP; Cai CY; Yu DY; Yan W; Wei QJ; Zhang Z; Huang XN; Liu L
Front Cardiovasc Med; 2022; 9():973279. PubMed ID: 36148059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]